Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates

NCT06894446 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Business decision due to practice in China

Conditions

Malnutrition, Infant
Enteral Feeding Intolerance

Interventions

DIETARY_SUPPLEMENT: Numeta G13%E
DIETARY_SUPPLEMENT: Compounded Parenteral Nutrition (cPN) solution

Sponsor

Baxter Healthcare Corporation